Cytoskeletal and phosphoinositide requirements for muscarinic receptor signaling to focal adhesion kinase and paxillin

J Neurochem. 1998 Mar;70(3):940-50. doi: 10.1046/j.1471-4159.1998.70030940.x.

Abstract

The mechanism whereby agonist occupancy of muscarinic cholinergic receptors elicits an increased tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin has been examined. Addition of oxotremorine-M to SH-SY5Y neuroblastoma cells resulted in rapid increases in the phosphorylation of FAK (t(1/2) = 2 min) and paxillin that were independent of integrin-extracellular matrix interactions, cell attachment, and the production of phosphoinositide-derived second messengers. In contrast, the increased tyrosine phosphorylations of FAK and paxillin were inhibited by inclusion of either cytochalasin D or mevastatin, agents that disrupt the cytoskeleton. Furthermore, phosphorylation of FAK and paxillin could be prevented by addition of either wortmannin or LY-294002, under conditions in which the synthesis of phosphatidylinositol 4-phosphate was markedly attenuated. These results indicate that muscarinic receptor-mediated increases in the tyrosine phosphorylation of FAK and paxillin in SH-SY5Y neuroblastoma cells depend on both the maintenance of an actin cytoskeleton and the ability of these cells to synthesize phosphoinositides.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Androstadienes / pharmacology
  • Cell Adhesion / physiology
  • Cell Adhesion Molecules / metabolism*
  • Cell Adhesion Molecules / physiology
  • Chromones / pharmacology
  • Cytochalasin D / pharmacology
  • Cytoskeletal Proteins / physiology*
  • Cytoskeleton / physiology
  • Enzyme Inhibitors / pharmacology
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • GTP-Binding Proteins / physiology
  • Humans
  • Lovastatin / analogs & derivatives
  • Lovastatin / pharmacology
  • Morpholines / pharmacology
  • Muscarinic Agonists / pharmacology
  • Neuroblastoma
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Paxillin
  • Phosphatidylinositol Phosphates / pharmacology
  • Phosphatidylinositols / physiology*
  • Phosphoproteins / physiology*
  • Phosphorus Radioisotopes
  • Phosphorylation
  • Protein-Tyrosine Kinases / metabolism*
  • Receptor, Insulin / metabolism
  • Receptors, Muscarinic / physiology*
  • Second Messenger Systems / drug effects
  • Second Messenger Systems / physiology*
  • Tumor Cells, Cultured / enzymology
  • Tyrosine / metabolism
  • Wortmannin

Substances

  • Actins
  • Androstadienes
  • Cell Adhesion Molecules
  • Chromones
  • Cytoskeletal Proteins
  • Enzyme Inhibitors
  • Morpholines
  • Muscarinic Agonists
  • Nucleic Acid Synthesis Inhibitors
  • PXN protein, human
  • Paxillin
  • Phosphatidylinositol Phosphates
  • Phosphatidylinositols
  • Phosphoproteins
  • Phosphorus Radioisotopes
  • Receptors, Muscarinic
  • phosphatidylinositol 4-phosphate
  • mevastatin
  • Cytochalasin D
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Tyrosine
  • Lovastatin
  • Protein-Tyrosine Kinases
  • Receptor, Insulin
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • PTK2 protein, human
  • GTP-Binding Proteins
  • Wortmannin